MedTrace Logo

Evaluation of Cardiovascular Risk Factors in Incident Dialysis Patients

NCT02813642 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2022-04-14

No results posted yet for this study

Summary

To evaluate the relationships between bone mineral markers levels at dialysis start and vascular calcification progression during a 2 year follow up

Conditions

Interventions

BIOLOGICAL

Plasma osteoprotegerin level

dosage of plasma osteoprotegerin

BIOLOGICAL

Plasma fibroblast growth factor 23 level

dosage of plasma fibroblast growth factor 23

PROCEDURE

Vascular calcification score

measurement of vascular calcification score by X-ray of the lateral abdominal aorta

Sponsors & Collaborators

  • University Hospital, Montpellier

    lead OTHER

Principal Investigators

  • Jean-Paul Cristol, Prof · CHU Lapeyronie, Department of Biochemistry and Hormonology, Montpellier, FRANCE

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-08
Primary Completion
2026-12-31
Completion
2027-02-28

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02813642 on ClinicalTrials.gov